Want to help change the course of Parkinson’s disease?
So do we.
When it comes to treating Parkinson’s disease, we believe that patients deserve more than just symptom management. That’s why we’re conducting the PADOVA study. We want to find out whether an investigational drug could slow progression of the disease.
The study will last for at least 2 years and includes a screening process, treatment period and follow-up period.
- Be between 50-85 years old
- Have been diagnosed with Parkinson’s disease for between 3 months and 3 years
*Other conditions apply